BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15362047)

  • 1. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.
    Lauer GM; Barnes E; Lucas M; Timm J; Ouchi K; Kim AY; Day CL; Robbins GK; Casson DR; Reiser M; Dusheiko G; Allen TM; Chung RT; Walker BD; Klenerman P
    Gastroenterology; 2004 Sep; 127(3):924-36. PubMed ID: 15362047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
    Lauer GM; Ouchi K; Chung RT; Nguyen TN; Day CL; Purkis DR; Reiser M; Kim AY; Lucas M; Klenerman P; Walker BD
    J Virol; 2002 Jun; 76(12):6104-13. PubMed ID: 12021343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
    Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
    Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
    Wertheimer AM; Miner C; Lewinsohn DM; Sasaki AW; Kaufman E; Rosen HR
    Hepatology; 2003 Mar; 37(3):577-89. PubMed ID: 12601356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
    Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M
    PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERAP1 allotypes shape the epitope repertoire of virus-specific CD8
    Kemming J; Reeves E; Nitschke K; Widmeier V; Emmerich F; Hermle T; Gostick E; Walker A; Timm J; Price DA; Hofmann M; Thimme R; James E; Neumann-Haefelin C
    J Hepatol; 2019 Jun; 70(6):1072-1081. PubMed ID: 30769005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of protective memory immune responses during hepatitis C virus reinfection.
    Abdel-Hakeem MS; Bédard N; Murphy D; Bruneau J; Shoukry NH
    Gastroenterology; 2014 Oct; 147(4):870-881.e8. PubMed ID: 25038432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus.
    Bharadwaj M; Thammanichanond D; Aitken CK; Moneer S; Drummer HE; Tracy S; Holdsworth R; Bowden S; Jackson D; Hellard M; Torresi J; McCluskey J
    Immunol Cell Biol; 2009; 87(6):464-72. PubMed ID: 19434069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
    Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
    J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Neumann-Haefelin C; Timm J; Spangenberg HC; Wischniowski N; Nazarova N; Kersting N; Roggendorf M; Allen TM; Blum HE; Thimme R
    Hepatology; 2008 Jun; 47(6):1824-36. PubMed ID: 18454507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
    Timm J; Li B; Daniels MG; Bhattacharya T; Reyor LL; Allgaier R; Kuntzen T; Fischer W; Nolan BE; Duncan J; Schulze zur Wiesch J; Kim AY; Frahm N; Brander C; Chung RT; Lauer GM; Korber BT; Allen TM
    Hepatology; 2007 Aug; 46(2):339-49. PubMed ID: 17559151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
    Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
    Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
    Lauer GM; Nguyen TN; Day CL; Robbins GK; Flynn T; McGowan K; Rosenberg ES; Lucas M; Klenerman P; Chung RT; Walker BD
    J Virol; 2002 Mar; 76(6):2817-26. PubMed ID: 11861849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.